United States Federal Circuit
Vanda Pharmaceuticals Inc. v. West Ward Pharmaceuticals, 16-2707
Affirming the decision of the district court holding, after a bench trial, that the asserted claims of a patent relating to the treatment of schizophrenia with iloperidone administered based on the genotype of the patient were infringed and not invalid.
Appellate Information
- Published 2018/04/13
Judges
- LOURIE
Court
- United States Federal Circuit